About Us
At a Glance
Careers
Management Team
Board of Directors
Target Markets
HCV Overview
Anti-Bacterial Overview
HIV Overview
Product Pipeline
ACH-1625
ACH-2684
ACH-2928
ACH-3102
ACH-1095
ACH-702
Elvucitabine
Discovery Programs
Discovery Technologies
News Center
Press Releases
Calendar
Resources
Investors
Corporate Information
Company News
Financial Information
Stock Information
Shareholder Services
Home
About Us
At a Glance
Careers
Management Team
Board of Directors
Target Markets
HCV Overview
Introduction to Viruses and HCV
HCV Market Challenges
HCV Market Opportunity
Anti-Bacterial Overview
HIV Overview
Product Pipeline
ACH-1625
ACH-1625 Program Overview
ACH-1625 Data Overview
ACH-2684
ACH-2928
ACH-3102
ACH-1095
ACH-702
Elvucitabine
Discovery Programs
Discovery Technologies
News Center
Press Releases
Calendar
Resources
Investors
Corporate Information
Company News
Financial Information
Stock Information
Shareholder Services
© Copyright 2012 Achillion Pharmaceuticals, Inc. All rights reserved. Page Last Updated Oct 25, 2011
